About this event
The invention of single-cell and spatial multi-omic approaches gave us the ability to interrogate diseases at an unprecedented resolution. However, using these advanced technologies creates large, complex datasets that require careful integration and analysis. This field is in its infancy. Progress is swift. To get the most out of your multi-omics analysis, it's important to stay right up-to-date with the latest developments, from the people who are operating at the leading edge of multi-omics research.
This webinar series will:
Plus, each session will include live Q&A with the speakers.
** Please note, by registering for webinar one, you will automatically receive access to subsequent webinars in the series. **
Single-Cell and Spatial Multi-Omics
Tuesday 17 January at 3 pm GMT/4 pm CET/10 am EDT
The webinar will highlight case studies of how the latest single-cell and spatial multi-omics approaches can best be applied, and what this means for your research going forward.
Talk 1: Beyond single cells: Subcellular single organelle spatial 'omics
James Eberwine, Elmer Holmes Bobst Professor of Systems Pharmacology and Translational Therapeutics, Co-Director Penn Program in Single Cell Biology, Co-Director Penn Center for Subcellular Biology, University of Pennsylvania Perelman School of Medicine
Talk 2: Multi-omics studies of the molecular evolution of glioblastoma
P.J. (Pim) French, Associate Professor, Erasmus MC
Talk 3: Application of spatial omics techniques to study disease
Yang Liu, Assistant Professor of Pathology, Yale School of Medicine
Multi-Omics to Understand Health and Disease
Tuesday 24 January at 3 pm GMT/4 pm CET/10 am EDT
Researchers are increasingly turning to multi-omics to better connect phenotype to genotype and variant to function in the context of health and disease. By deconstructing diseases using multi-omics, we can deduce the pathways that are involved in disease – unlocking insights that can influence our ability to intercept disease onset. In this webinar, we will seek to understand the intricate changes that cause disease in cells.
Talk 1: Using single-cell multi-omics to investigate the immune response to COVID-19
Emily Stephenson, Senior Research Associate, Newcastle University
Talk 2: Joint profiling of multi-omics within the same DNA molecules
Yaping Liu, Assistant Professor, Cincinnati Children’s Hospital Medical Center
Multi-Omics in Target Discovery
Tuesday 31 January at 3 pm GMT/4 pm CET/10 am EDT
Producing successful drugs that hit the market is dependent on a better understanding of disease biology. With plenty of omics data to hand, how can we integrate these datasets to get the deepest insights, faster? In this webinar, we will showcase data analysis examples from pharma using multi-omics for drug discovery.
Talk 1: Multi-omics in drug discovery
Philippe Sanseau, Senior Director of Computational Biology and Senior Fellow, GSK
Talk 2: Multi-omics approaches to inform disease mechanism and drug target identification
Andrew Jarnuczak, Associate Principal Scientist, AstraZeneca
Front Line Genomics is a genomics-focused media company, with a social mission to deliver the benefits of genomics to patients faster. We organise the Festival of Genomics, digital events and webinars. We also produce reports and operate a content-rich website.
Share this event